Neurology

FDA Okays Pitolisant (Wakix) for Narcolepsy

The FDA has approved pitolisant, a first-in-class, nonscheduled treatment option with a novel mechanism of action for adults with narcolepsy.
FDA Approvals

Source link

Related posts

FDA approves new drug to treat adults with relapsing forms of MS

Newsemia

Telemedicine in the PM&R Practice: The TeleRehab Visit

Newsemia

Editors' note: Quality of life predicts outcome of deep brain stimulation in early Parkinson disease

Newsemia

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Privacy & Cookies Policy

COVID-19

COVID-19 (Coronavirus) is a new illness that is having a major effect on all businesses globally LIVE COVID-19 STATISTICS FOR World